Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ross Acquisition Corp II Cl A (NY: ROSS )

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, Mar 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ross Acquisition Corp II Cl A

Ross Acquisition Corp II Announces Suspension and Expected De-Listing from the New York Stock Exchange and Intention to Seek Listing on the Nasdaq Stock Market
From Ross Acquisition Corp II
Via GlobeNewswire
Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
From Ross Acquisition Corp II
Via GlobeNewswire
Ross Acquisition Corp II Announces Shareholder Approval of Extension of Deadline to Complete a Business Combination
From Ross Acquisition Corp II
Via GlobeNewswire
Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
From Ross Acquisition Corp II
Via GlobeNewswire
Ross Acquisition Corp II Receives NYSE Notice Regarding Delayed Form 10-Q Filing
From Ross Acquisition Corp II
Via GlobeNewswire
Retail Earnings Provided Clear Customer Behavior Insights That Benefited Discount Retailers And Left High-End Retailers In The Dark
Like TJX Corporation (NYSE: TJX), Ross Stores Inc (NASDAQ: ROSS) thrived as consumers drifted away from high-end retailers. 
Via Benzinga
China PMI Surprises To Upside
Good Morning Everyone! China stuns the world with manufacturing activity expanding at the fastest pace in more than a decade in February.  The Hong Kong stock index is up +4%. Maybe the economy won’t... 
Via Benzinga
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in... 
Via Talk Markets
Neurodegenerative Diseases Focused Company Goes Public Via Wilbur Ross-Backed SPAC, Joins Alzheimer's Race To Compete Biogen
Via Benzinga
Some Bullish Moves Worth Mentioning In A Bearish Market
May has been another anemic month for every equity index, from the Nasdaq to the Dow. As a few too many Q1 earnings reports miss their marks, each day seems to bring more uncertainty. As the tickers... 
Via Talk Markets
Ross Stores Stock Falls On Weak Q3 Outlook
Ross Stores Inc (NASDAQ: ROSS) reported second-quarter FY21 sales growth of 78.9% year-on-year, to $4.80 billion, beating the analyst consensus of $4.45 billion.... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.